Elite in Breast Cancer

Icro Meattini

Florence, IT 
Elite in Breast Cancer
Florence, IT 
OverviewLocationsClinical Research

Overview

Icro Meattini practices in Florence, Italy. Meattini is rated as an Elite expert by MediFind in the treatment of Breast Cancer. Their top areas of expertise are Breast Cancer, Triple-Negative Breast Cancer, Prostate Cancer, Mastectomy, and Prostatectomy.

Their clinical research consists of co-authoring 318 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 209 articles and participated in 3 clinical trials in the study of Breast Cancer.

Locations

Florence, Italy
Other Locations
Brescia, Italy
Naples, Italy
Careggi, Italy

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

ExclUsive endocRine Therapy Or Radiation theraPy for Women Aged ≥70 Years With Luminal A-like Early Stage Breast Cancer (EUROPA): a Randomized Phase 3 Trial
ExclUsive endocRine Therapy Or Radiation theraPy for Women Aged ≥70 Years With Luminal A-like Early Stage Breast Cancer (EUROPA): a Randomized Phase 3 Trial
Enrollment Status: Active_not_recruiting
Publish Date: August 29, 2025
Intervention Type: Drug, Radiation
Study Phase: Phase 3
Cardiological Monitoring and Safety of Ultra-hypofractionated Whole Breast Irradiation After Breast-conserving Surgery for Patients Affected by Breast Cancer: an Observational Prospective Cohort Study
Cardiological Monitoring and Safety of Ultra-hypofractionated Whole Breast Irradiation After Breast-conserving Surgery for Patients Affected by Breast Cancer: an Observational Prospective Cohort Study
Enrollment Status: Completed
Publish Date: July 20, 2023
Intervention Type: Radiation
Role of ACE Inhibitors and Beta Blockers as Cardiotoxicity Prevention in Breast Cancer Patients Treated With (Neo)Adjuvant Anthracyclines and/or Trastuzumab: a Four Arm, Placebo Control, Randomized Trial
Role of ACE Inhibitors and Beta Blockers as Cardiotoxicity Prevention in Breast Cancer Patients Treated With (Neo)Adjuvant Anthracyclines and/or Trastuzumab: a Four Arm, Placebo Control, Randomized Trial
Enrollment Status: Unknown
Publish Date: February 01, 2022
Intervention Type: Drug
Study Drugs: Bisoprolol, Ramipril
Study Phase: Phase 3
View 2 Less Clinical Trials

317 Total Publications

Impact of BRCA in patients undergoing abiraterone ± stereotactic body radiotherapy: the ARTO trial.
Impact of BRCA in patients undergoing abiraterone ± stereotactic body radiotherapy: the ARTO trial.
Journal: BJU international
Published: December 15, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Meattini's expertise for a condition
ConditionClose
    View All 7 Advanced Conditions
    View All 24 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile